Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia

Allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially curative treatment of chronic myeloid leukemia (CML). Optimal conditioning intensity for allo-HCT for CML in the era of tyrosine kinase inhibitors (TKIs) is unknown. Using the Center for International Blood and Marrow Transpla...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Blood Adv
Κύριοι συγγραφείς: Chhabra, Saurabh, Ahn, Kwang Woo, Hu, Zhen-Huan, Jain, Sandeep, Assal, Amer, Cerny, Jan, Copelan, Edward A., Daly, Andrew, DeFilipp, Zachariah, Gadalla, Shahinaz M., Gale, Robert Peter, Ganguly, Siddhartha, Hamilton, Betty K., Hildebrandt, Gerhard Carl, Hsu, Jack W., Inamoto, Yoshihiro, Kanate, Abraham S., Khoury, H. Jean, Lazarus, Hillard M., Litzow, Mark R., Nathan, Sunita, Olsson, Richard F., Pawarode, Attaphol, Ringden, Olle, Rowe, Jacob M., Saad, Ayman, Savani, Bipin N., Schouten, Harry C., Seo, Sachiko, Shah, Nirav N., Solh, Melhem, Stuart, Robert K., Ustun, Celalettin, Woolfrey, Ann E., Yared, Jean A., Alyea, Edwin P., Kalaycio, Matt E., Popat, Uday, Sobecks, Ronald M., Saber, Wael
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society of Hematology 2018
Θέματα:
Transplantation
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6234373/
https://ncbi.nlm.nih.gov/pubmed/30396912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018024844
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια